The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1502
August 29, 2016
View Complete Issue         Table of Contents 2019 
AspireAssist - A New Device for Weight Loss
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
AspireAssist - A New Device for Weight Loss
August 29, 2016 (Issue: 1502)
The FDA has approved AspireAssist (Aspire Bariatrics), a weight-loss device that permits patients to drain a portion of their stomach contents through a gastrostomy tube into a toilet after each meal. It is approved for long-term use in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: AspireAssist - A New Device for Weight Loss
Article code: 1502a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.